Document rxz51v5ovga8Lv42r4GLMn6KJ

ES-36S2 REV.!2-13 :ESTAUU13HEU 1602 E. I. pu Po n t d e Ne mo u r s & Co mp a n y INCORPORATED Ha s k e l l . La b o r a t o r y f o r To x ic o l o g y AND INDUSTRIAL MEDICINE P.O. Box 50. El k t o n Ro a d Ne w a r k . De l a w a r e 19714 CENTRAL RESEARCH AND DEVELOPMENT DEPARTMENT <- -./o J Qz ec ; A.B. Palmer-C&P 8-16270 C.R. Hutter-C&P, 8-16228 W.C, Krauss H.J. ft oehiiiiowicz June 12, 1989 TO; C. F. REINHARDT E. F. S TUI A FROM; G. L. KENNEDY, JR. ^ LEAD - CANCER I attended a 1-day research workshop cosponsored by EPA and ILZRO. EPA is working on classification and quantitation of lead and its compounds as carcinogens. ILZRO has a number of research programs armed either directly or peripherally at the question. The specific request of Du Pont was to make available the data from the 2 year feeding studies with lead acetate. I agreed that we would work toward that goal - EPA feels that the studies are the best available and ILZRO supports dissemination of that information. A key to the findings appears to be the relationship between kidney damage and kidney cancer. Goyer (UNC) has a research program along these lines and could serve as a resource here. EPS - we need to outline a course of action.; I 11 interact with Jerry Cole (ILZRO) and Sill Fariand (EPA) to get some idea of timing . N 29287 DUP040011180